Sjogren's syndrome is a chronic, multisystem immunological disorder that is characterised by progressive destruction of the exocrine glands, accompanied by a variety of autoimmune phenomena. This syndrome can present either as a primary disorder or as a component of other autoimmune diseases, such as rheumatoid arthritis, scleroderma, or systemic lupus erythematosus. 1 Virtually any organ system of the body can be affected.' The most characteristic symptoms are keratoconjunctivitis sicca and xerostomia, resulting from a destructive mononuclear infiltration of the lachrymal and salivary glands, respectively. Similar mononuclear infiltrates invading visceral organs can give rise to such extraglandular manifestations as interstitial pulmonary fibrosis,2 renal tubular acidosis,3 and Hashimoto's thyroiditis. 4 Neurological features are well documented in primary Sj6gren's syndrome, and peripheral nervous system disease is reported in 10-32% of patients with this disorder5 6: mixed polyneuropathy confined to the lower extremities and mononeuritis multiplex are the most commonly observed.5 These neuropathies occur after the diagnosis of Sjogren's syndrome is well established and they are usually associated with systemic vasculitis. 5 To date, the mean duration of our patients' neuropathy has been years (five to 13). All but one patient remain ambulatory in spite of the neurological symptoms. In these patients the principal impairment was usually the proprioceptive defect present in the hand affected at the onset of the neuropathy. One patient (No 3) still has the sensory deficit confined to the arms 13 years after the onset of neuropathy (table 1) . On the other hand, the neuropathy in patient No 5 took a severe progressive course two years after the onset of the disease in spite of treatment with high doses of prednisone (1 mg/kg daily). Two patients (Nos 1 and 3) received low doses of prednisone (5 mg daily) because of sicca syndrome without an apparent improvement in neuropathy. The other two patients received no treatment. During follow up none of the patients developed systemic vasculitis or lymphoma; patient No 2 developed Hashimoto's thyroiditis.
Discussion
Unlike previous case reports our study shows that not only can neuropathy precede the diagnosis of Siogren's syndrome but it may be present even when a definite diagnosis of Sjogren's syndrome cannot be made. Therefore, appropriate tests must be repeated during follow up to confirm the diagnosis of Sjogren's syndrome. Moreover, the present series shows that these patients have remarkably similar clinical and electromyographic features, which differentiate this neuropathy from the more common neuropathies caused by vasculitic disease of the peripheral nerve. In all our patients symptoms started in one hand and slowly progressed to the other extremities. The neuropathy remained asymmetrical even years after its onset. All modalities of sensation were usually affected but there was always a predominance ofthe vibratory and joint position senses. Adie's pupil syndrome was observed in three ofour patients. Autonomic polyneuropathy has been described in Sjogren's syndrome associated with sensory9 or sensorimotor neuropathy.6 Our patients did not complain of other symptoms of autonomic dysfunction but no studies were done to determine if a more widespread subclinical autonomic neuropathy was present.
The absence of motor weakness, the presence of an asymmetrical sensory neuropathy initially affecting the arms, the fact that the vibratory and joint position senses syndrome rather than other modalities of sensation were affected, and the association with Adie's pupil syndrome or trigeminal sensory neuropathy are clues to the clinical diagnosis of this neuropathy. Some 
